Page last updated: 2024-11-02

piracetam and Bacterial Disease

piracetam has been researched along with Bacterial Disease in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
" Clinicians should be mindful that standard dosing of these agents may not achieve typical target concentrations in this clinical scenario."1.39Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient. ( Arora, S; Cook, AM; Davis, J; Pittman, T, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cook, AM1
Arora, S1
Davis, J1
Pittman, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Relation Between Renal Resistive Index, Glomerular Hyperfiltration and Hyperdynamic Circulation in Critically Ill Patients With Trauma or Sepsis.[NCT02560402]40 participants (Actual)Observational2015-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for piracetam and Bacterial Disease

ArticleYear
Augmented renal clearance of vancomycin and levetiracetam in a traumatic brain injury patient.
    Neurocritical care, 2013, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; Brain Injuries; Drug Monitoring; Femal

2013